These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3061015)

  • 1. Reimbursement issues in clinical oncology.
    Vogelzang NJ; Chabner BA; Periman P; Ohrt DK; McCann BC; Burns JM; Bayer R
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):34-43. PubMed ID: 3061015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursement issues facing patients, providers, and payers.
    Antman K
    Cancer; 1993 Nov; 72(9 Suppl):2842-5. PubMed ID: 8402516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-party payers and the cost of biomedical research.
    Iltis AS
    Kennedy Inst Ethics J; 2005 Jun; 15(2):135-60. PubMed ID: 16149205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Private payers and cancer care: land of opportunity.
    Klein I; Kolodziej M
    J Oncol Pract; 2014 Jan; 10(1):15-9. PubMed ID: 24084888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
    Bennett CL; Stinson TJ; Vogel V; Robertson L; Leedy D; O'Brien P; Hobbs J; Sutton T; Ruckdeschel JC; Chirikos TN; Weiner RS; Ramsey MM; Wicha MS
    J Clin Oncol; 2000 Aug; 18(15):2805-10. PubMed ID: 10920127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Payment and coverage issues affecting medical oncology.
    Bailes JS
    Breast Cancer Res Treat; 1993; 25(2):119-26. PubMed ID: 8347844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An American approach to health system reform.
    Holahan J; Moon M; Welch WP; Zuckerman S
    JAMA; 1991 May; 265(19):2537-40. PubMed ID: 2020072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness and reimbursement in patient care.
    Antman KH; Aledort LM; Yarbro J; Wilensky G; Wojcik S; Monaco GP; Windham S
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):32-45. PubMed ID: 2508228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost considerations in the management of cancer in the older patient.
    McKoy JM; Fitzner KA; Edwards BJ; Alkhatib M; Tigue CC; Nonzee NJ; Bolden CR; Bennett CL
    Oncology (Williston Park); 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim. PubMed ID: 17722744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European perspective on the costs and cost-effectiveness of cancer therapies.
    Drummond MF; Mason AR
    J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and coverage of novel cancer agents in managed care.
    Bailes JS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third party concerns.
    Hertenstein RD
    Cancer; 1989 Jul; 64(1 Suppl):319; discussion 320-3. PubMed ID: 2497950
    [No Abstract]   [Full Text] [Related]  

  • 15. Reimbursement of biotherapy: present status, future directions--perspectives of the office-based oncology nurse.
    Xistris D
    Semin Oncol Nurs; 1992 Nov; 8(4 Suppl 1):8-12. PubMed ID: 1462057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the American Society of Clinical Oncology Ask for Peer Review Before Publishing Its Advocacy Research?
    Bach PB
    J Clin Oncol; 2016 Dec; 34(36):4447-4448. PubMed ID: 27998217
    [No Abstract]   [Full Text] [Related]  

  • 17. End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes?
    McGuire A; Drummond M; Martin M; Justo N
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):599-605. PubMed ID: 26176751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care policies affecting the treatment of patients with cancer and cancer research.
    Mortenson LE
    Cancer; 1994 Oct; 74(7 Suppl):2204-7. PubMed ID: 8087793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National health insurance: comments on selected issues.
    Ball RM
    Science; 1978 May; 200(4344):864-70. PubMed ID: 417401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumer nemesis of the 80s: rising health care cost.
    Baker BS
    Health Values; 1986; 10(4):19-24. PubMed ID: 10311575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.